Waylivra
Jul 24, 2020
Rejections and Withdrawals: Familial Chylomicronemia Syndrome Market Needs a Therapy sufficiently Effective, sufficiently Affordable
A rare autosomal recessive disorder, Familial chylomicronemia syndrome (FCS) affects 1 in 1 to 2 million people (Burnett and Hegele, 1999; Pouwels et al. 2008). As per DelveInsight, the total Familial chylomicronemia syndrome diagnosed prevalent population in the 7MM [the US, EU4 (Germany, Franc...
Read More...
Mar 05, 2019
ColdZyme inactivates viruses; Med for rare genetic disease; Common oral bacteria accelerate Colon cancer; CEPI and CureVac to develop an mRNA vaccine; Celastrol’s effectiveness
ColdZyme inactivates 99% of viruses causing common cold An Oral spray ColdZyme contains a solution of proteolytic enzyme trypsin and glycerol, which happens to shorten the duration of the common cold and also reduces its gravity. A recent research by Enzymatica-a Swedish based life sciences company shows the cli...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
